Category Archives: TB

Study projects drug-resistant tuberculosis transmissions to climb in four countries

By on .

Using data on outcomes and impacts of tuberculosis across four countries with some of the highest rates of the disease, researchers from the U.S. Centers for Disease Control and Prevention have found indications that person-to-person transmission will drive rising rates of TB that does not respond to treatments of first and second resort over the […]

WHO TB Guidelines updated to reflect effective patient-centered practices

By on .

With an emphasis on treatment that reaches all people sick with tuberculosis, and systems responsive to and supportive of patients, the World Health Organization has released an update to its tuberculosis care guidelines, highlighting issues that many of the countries with the highest burden of TB disease continue to fall short of confronting. The update […]

National Action Plan for Combatting MDR-TB continues to be a work in progress

By on .

First year report describes assessments of needs, strategies, opportunities In December 2015, tuberculosis response advocates welcomed the release of a White House National Action Plan for Combating Multidrug-Resistant Tuberculosis with wary optimism. Promised months earlier as part of a broader administration initiative to tackle antimicrobial resistance, a set of specific goals to counter the growing […]

We’re reading about tuberculosis, and why one day a year is not enough

By on .

Friday was the official World TB Day, a single calendar page set aside to send the message that TB continues to spread — with 10.4 million cases last year, a million among children — that TB continues to take a needless toll — of 1.8 million in 2016 alone, that drug-resistant TB poses a growing worldwide threat, and […]

The multi-national network of TB Portals advances tuberculosis research

By on .

The following is a guest post by Jessica Taaffe, PhD In the current environment of limited tuberculosis research funding, TB research can benefit significantly from data-centric collaborations, as researchers can learn from the work and experiences of others, propelling their own research forward, and they facilitate larger meta-analyses of existing data. The TB Portals program […]

CDC: Domestic TB data shows need to expand screening, testing, treatment reach

By on .

U.S. Centers for Disease Control and Prevention report finds newly discovered tuberculosis higher among foreign-born with more than 10 years in United States than among more recent arrivals With a drop in the numbers of new tuberculosis patients between 2015 and 2016, TB incidence in the U.S. is once again going in the right direction, […]

Adding up tolls of drug resistance, threats to research and hurdles to progress, TB survivors, scientists and advocates gather on Capitol Hill

By on .

“We’re not here because tuberculosis is like the common cold and makes you feel bad, we’re here because TB kills people” Washington, DC – From a six-year-old girl who came home to the U.S. sick after a visit to her grandparents in India, and from a long-distance runner from Peru, an audience on Capitol Hill […]

TB partners, patients ask: How does a bacterium responsible for nearly a third of drug-resistance deaths not make list of R&D priority pathogens?

By on .

Exclusion of tuberculosis from WHO “catalogue of 12 bacteria that pose the greatest threat to human health,” threatens development of medicines to treat world’s leading infectious disease killer, health advocates and leaders say While the unveiling of a list highlighting the need to fund drug development against specific pathogens represented just a beginning  for some […]

TB training for just 5 to 9 percent of private pharmacies not enough for public health impact

By on .

The following is a guest post by Emily Demotte Lisinopril 20 mg by mouth at eight AM? Check. Having already verified the patient’s identification, I scanned the medication barcodes into the computer one by one, performing the third, and final, confirmation of the “five rights” of medication administration – right patient, right drug, right dose, […]

Stalled TB drug gets new chance with agreement between Johns Hopkins and UN-backed organization

By on .

License agreement with Medicine Patent Pool will speed clinical development of drug considered promising for improved treatment of tuberculosis responsive and resistant to existing drugs With all regimens to treat tuberculosis requiring multiple drugs, and all but two of those drugs tracing their lineage to the middle of the last century, excitement was high in […]